Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
370 |
|
| Actual shortage: | 9 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 5 (1%) | |
| Resolved: | 354 (96%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
52 (14%) |
|
Overdue reports |
2 (18%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2021-03-26 | 2022-04-13 | 136448 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Avoided shortage | 2022-04-13 | 2022-07-15 | 158783 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2022-04-13 | 2022-07-15 | 158786 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2024-11-21 | 2025-02-08 | 243515 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2025-03-13 | 2025-03-21 | 252534 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2025-08-18 | 2025-09-10 | 265518 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2025-10-01 | 2025-12-05 | 268276 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2025-11-15 | 2025-12-05 | 271950 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Anticipated shortage | 2025-12-22 | 2025-12-22 | 274900 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Anticipated shortage | 2025-12-22 | 2025-12-22 | 274903 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-03-26 | 2021-04-16 | 136455 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-03-26 | 2021-04-16 | 136460 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-10-21 | 2021-12-31 | 147731 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-04-13 | 2022-09-01 | 158789 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-04-13 | 2022-08-29 | 158792 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-01-16 | 2023-04-04 | 181154 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-01-16 | 2023-11-17 | 181157 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2025-05-15 | 2025-09-18 | 257446 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2025-05-15 | 2025-12-09 | 257455 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2021-03-26 | 2021-04-16 | 136451 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2